Ezetimibe Entèmedyè ZT-5 CAS 189028-95-3 Pite ≥98.0% (HPLC) Faktori Segondè Kalite
| Non Chimik | (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one |
| Sinonim | Ezetimibe Entèmedyè ZT-5 |
| Nimewo CAS | 189028-95-3 |
| Nimewo CAT | RF-PI146 |
| Estati Stock | Nan stock, pwodiksyon echèl jiska dè santèn de kilogram |
| Fòmil molekilè | C20H20FNO4 |
| Pwa molekilè | 357.38 |
| Mak | Ruifu Chimik |
| Atik | Espesifikasyon |
| Aparans | Poud blan oswa blan |
| Pite / Metòd analiz | ≥98.0% (HPLC) |
| Enpurte ZT-4 | ≤1.0% |
| Enantiomère | ≤0.20% |
| Single enpurte | ≤1.5% |
| Enpurte total | ≤2.0% |
| Tès Creole | Enterprise Standard |
| Itilizasyon | Ezetimibe (CAS: 163222-33-1) Entèmedyè |
Shanghai Ruifu Chemical Co, Ltd se manifakti dirijan ak founisè nan (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2 -one (CAS: 189028-95-3) ak kalite siperyè.Li se yon entèmedyè nan Ezetimibe (CAS: 163222-33-1)
Ezetimibe (CAS: 163222-33-1) se yon dwòg anti-iperlipidemi ki itilize pou bese nivo kolestewòl nan plasma.Li endike kòm yon terapi adjwen nan rejim alimantè pou rediksyon wo nivo total-C, LDL-C, ak ApoB nan pasyan ki soufri prensipal (eterozigot familyal ak ki pa fanmi) hypercholesterolemia.Li se tou itilize nan terapi konbinezon ak HMG-CoA reduktaz inhibiteurs.Ezetimibe pa anpeche sentèz la kolestewòl nan fwa a, oswa ogmante eskresyon asid kòlè.
![4-[[(4-Fluorophenyl)imino]methyl]-phenol CAS 3382-63-6 Ezetimibe Entèmedyè Pite ≥99.0% Faktori](https://www.ruifuchemical.com/uploads/76de86b1-300x300.jpg)
Ekri mesaj ou la a epi voye l ba nou